Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Toward a safer and more secure US bioeconomy

To enhance the safety and security of the US bioeconomy, a new public–private partnership should be established to facilitate information sharing and threat analysis among industry, government and academia, and to develop and deploy safeguards.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Carlson, R. H., Sbragia, C. L. & Sixt, K. M. Beyond biological defense: biotech in U.S. national security and great power competition. https://www.ida.org/research-and-publications/publications/all/b/be/beyond-biological-defense-biotech-in-us-national-security-and-great-power-competition (IDA, 2021).

  2. Executive order on advancing biotechnology and biomanufacturing innovation for a sustainable, safe, and secure American bioeconomy. https://www.whitehouse.gov/briefing-room/presidential-actions/2022/09/12/executive-order-on-advancing-biotechnology-and-biomanufacturing-innovation-for-a-sustainable-safe-and-secure-american-bioeconomy/ (White House, 2022).

  3. National Academies of Sciences, Engineering and Medicine. Safeguarding the Bioeconomy https://nap.nationalacademies.org/catalog/25525/safeguarding-the-bioeconomy (National Academies Press, 2020).

  4. Attal-Juncqua, A., Getz, J., Morhard, R. & Gronvall, G. K. mSphere https://doi.org/10.1128/msphere.00084-24 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Carter, S. & DiEuliis, D. Health Secur. 17, 403–406 (2019).

    Article  PubMed  Google Scholar 

  6. Carter, S. R. & DiEuliis, D. Synthetic biology industry practices and opportunities for biosecurity and potential roles for the U.S. Government. https://wmdcenter.ndu.edu/Portals/97/SynBio-Industry-and-Biosecurity-Nov-201912.pdf (National Defense University, 2019).

  7. Proestou, M., Schulz, N. & Feindt, P. H. Ambio 53, 376–388 (2024).

    Article  PubMed  Google Scholar 

  8. Halford, C. & Harper, M. ASIAS: Aviation Safety Information Analysis and Sharing. In 2008 IEEE/AIAA 27th Digital Avionics Systems Conference https://doi.org/10.1109/DASC.2008.4702784 (IEEE, 2008).

  9. Rose, S., Alexanian, T., Langenkamp, M., Cozzarini, H. & Diggans, J. Appl. Biosaf. 29, 159–171 (2024).

    Article  PubMed  Google Scholar 

  10. ISO 35001:2019. Biorisk management for laboratories and other related organizations. https://www.iso.org/standard/71293.html (ISO, 2019).

  11. CHIPS Act of 2022. https://www.congress.gov/117/plaws/publ167/PLAW-117publ167.pdf (Government Publishing Office, 2022).

  12. Administration for Strategic Preparedness and Response. Screening framework guidance for providers and users of synthetic nucleic acids. https://aspr.hhs.gov/legal/synna/Documents/SynNA-Guidance-2023.pdf (Department of Health and Human Services, 2023).

  13. National Science and Technology Council. Framework for nucleic acid synthesis screening. https://www.whitehouse.gov/wp-content/uploads/2024/04/Nucleic-Acid_Synthesis_Screening_Framework.pdf (Office of Science and Technology Policy, 2024).

  14. United States Government policy for oversight of dual use research of concern and pathogens with enhanced pandemic potential. https://www.whitehouse.gov/wp-content/uploads/2024/05/USG-Policy-for-Oversight-of-DURC-and-PEPP.pdf (Executive Office of the President, 2024).

Download references

Acknowledgements

This work was supported by the MITRE Corporation. We are grateful to Elizabeth Gehman (the MITRE Corporation) for her constructive comments and recommendations during the preparation of this manuscript.

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization: M.C.W., K.J.R., J. Dileo. Methodology: M.C.W., K.J.R., J. Dileo. Investigation: M.C.W., K.J.R., M.J.S., S.R.C., R.L.M., A.A.-J., J. Diggans., J. Dileo. Project administration: M.C.W. Supervision: J. Dileo. Writing – original draft: M.C.W. Writing – review & editing: K.J.R, M.J.S., S.R.C., R.L.M., A.A.-J., J. Diggans, J. Dileo.

Corresponding author

Correspondence to Matthew C. Watson.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Watson, M.C., Rambhia, K.J., Seltzer, M.J. et al. Toward a safer and more secure US bioeconomy. Nat Biotechnol 43, 23–25 (2025). https://doi.org/10.1038/s41587-024-02519-2

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41587-024-02519-2

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research